FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3109024654> ?p ?o ?g. }

• W3109024654 abstract "Background: Pirfenidone is an anti-fibrotic agent used to treat patients with idiopathic pulmonary fibrosis (IPF). Managing adverse drug events and ensuring compliance with pirfenidone treatment for a prolonged period are important to reduce the rate of disease progression. To maximize the benefits of pirfenidone treatment, we established and evaluated an ambulatory care pharmacy practice, a model of pharmacist–physician collaborative management, for patients receiving pirfenidone. Methods: We conducted a retrospective chart review of 76 consecutive patients treated with pirfenidone in the Kobe City Medical Center General Hospital, Japan, between January 2012 and January 2019. The first group (61 patients) received pirfenidone treatment as conventional management, whereas the second group (15 patients) started pirfenidone based on collaborative pharmacist–physician management. The drug discontinuation rate and time to drug discontinuation were compared between the groups. To analyze factors associated with pirfenidone discontinuation, we used a multivariate Cox regression analysis to evaluate the baseline characteristics of patients, including those receiving the collaborative management. Clinical outcomes were compared using a propensity score matched analysis. Results: In the collaborative management group, pharmacists made 56 suggestions, including suggestions for supportive care (51 suggestions), to the physicians. Among these suggestions, 52 were accepted by the physicians. The discontinuation rates at 3 [6.7% (1/15) vs. 26.2% (16/61)] and 6 [9.1% (1/11) vs. 36.1% (22/61)] months were lower in the collaborative management group than in the conventional management group. Multivariate analysis revealed that collaborative management [hazard ratio (HR) 0.34, 95% CI 0.08–0.96, p = 0.041] and predicted baseline forced vital capacity &lt;60% (HR 2.13, 95% CI 1.17–3.85, p = 0.015) were significantly associated with pirfenidone discontinuation. The time to drug discontinuation was also significantly longer in the collaborative management group than in the conventional management group ( p = 0.034, log-rank test). Propensity score matched analysis confirmed a significant correlation between collaborative management and drug discontinuation time (HR 0.20, 95% CI 0.03–0.84, p = 0.027). Conclusions: We established an ambulatory care pharmacy practice for out-patients with IPF receiving pirfenidone. The results suggest that collaborative management may help prevent pirfenidone discontinuation compared with conventional management." @default.
• W3109024654 created "2020-12-07" @default.
• W3109024654 creator A5006122700 @default.
• W3109024654 creator A5013978072 @default.
• W3109024654 creator A5031993878 @default.
• W3109024654 creator A5032356408 @default.
• W3109024654 creator A5036577393 @default.
• W3109024654 creator A5039054605 @default.
• W3109024654 creator A5039997237 @default.
• W3109024654 creator A5049047018 @default.
• W3109024654 creator A5051133871 @default.
• W3109024654 creator A5062454590 @default.
• W3109024654 creator A5063715314 @default.
• W3109024654 creator A5065290513 @default.
• W3109024654 creator A5077850152 @default.
• W3109024654 date "2020-11-26" @default.
• W3109024654 modified "2023-09-26" @default.
• W3109024654 title "Effectiveness of Pharmacist–Physician Collaborative Management for Patients With Idiopathic Pulmonary Fibrosis Receiving Pirfenidone" @default.
• W3109024654 cites W1801975325 @default.
• W3109024654 cites W1938547050 @default.
• W3109024654 cites W1986700094 @default.
• W3109024654 cites W2014925790 @default.
• W3109024654 cites W2022095323 @default.
• W3109024654 cites W2057292199 @default.
• W3109024654 cites W2086655418 @default.
• W3109024654 cites W2107723678 @default.
• W3109024654 cites W2117488044 @default.
• W3109024654 cites W2142941142 @default.
• W3109024654 cites W2168666423 @default.
• W3109024654 cites W2208096782 @default.
• W3109024654 cites W2235270260 @default.
• W3109024654 cites W2319711690 @default.
• W3109024654 cites W2476684925 @default.
• W3109024654 cites W2510319197 @default.
• W3109024654 cites W2531331592 @default.
• W3109024654 cites W2597638604 @default.
• W3109024654 cites W2611139918 @default.
• W3109024654 cites W2752515438 @default.
• W3109024654 cites W2774138788 @default.
• W3109024654 cites W2787583095 @default.
• W3109024654 cites W2799479598 @default.
• W3109024654 cites W2803426914 @default.
• W3109024654 cites W2808015431 @default.
• W3109024654 cites W2897924093 @default.
• W3109024654 cites W2903949926 @default.
• W3109024654 cites W2918620711 @default.
• W3109024654 cites W2924332997 @default.
• W3109024654 cites W2945205783 @default.
• W3109024654 cites W2948456002 @default.
• W3109024654 cites W4296612182 @default.
• W3109024654 doi "https://doi.org/10.3389/fphar.2020.529654" @default.
• W3109024654 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7725709" @default.
• W3109024654 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/33324201" @default.
• W3109024654 hasPublicationYear "2020" @default.
• W3109024654 type Work @default.
• W3109024654 sameAs 3109024654 @default.
• W3109024654 citedByCount "3" @default.
• W3109024654 countsByYear W31090246542022 @default.
• W3109024654 countsByYear W31090246542023 @default.
• W3109024654 crossrefType "journal-article" @default.
• W3109024654 hasAuthorship W3109024654A5006122700 @default.
• W3109024654 hasAuthorship W3109024654A5013978072 @default.
• W3109024654 hasAuthorship W3109024654A5031993878 @default.
• W3109024654 hasAuthorship W3109024654A5032356408 @default.
• W3109024654 hasAuthorship W3109024654A5036577393 @default.
• W3109024654 hasAuthorship W3109024654A5039054605 @default.
• W3109024654 hasAuthorship W3109024654A5039997237 @default.
• W3109024654 hasAuthorship W3109024654A5049047018 @default.
• W3109024654 hasAuthorship W3109024654A5051133871 @default.
• W3109024654 hasAuthorship W3109024654A5062454590 @default.
• W3109024654 hasAuthorship W3109024654A5063715314 @default.
• W3109024654 hasAuthorship W3109024654A5065290513 @default.
• W3109024654 hasAuthorship W3109024654A5077850152 @default.
• W3109024654 hasBestOaLocation W31090246541 @default.
• W3109024654 hasConcept C104863432 @default.
• W3109024654 hasConcept C126322002 @default.
• W3109024654 hasConcept C177713679 @default.
• W3109024654 hasConcept C194828623 @default.
• W3109024654 hasConcept C207103383 @default.
• W3109024654 hasConcept C2777714996 @default.
• W3109024654 hasConcept C2778341716 @default.
• W3109024654 hasConcept C2778715236 @default.
• W3109024654 hasConcept C2779457091 @default.
• W3109024654 hasConcept C2779832356 @default.
• W3109024654 hasConcept C38180746 @default.
• W3109024654 hasConcept C44249647 @default.
• W3109024654 hasConcept C512399662 @default.
• W3109024654 hasConcept C71924100 @default.
• W3109024654 hasConceptScore W3109024654C104863432 @default.
• W3109024654 hasConceptScore W3109024654C126322002 @default.
• W3109024654 hasConceptScore W3109024654C177713679 @default.
• W3109024654 hasConceptScore W3109024654C194828623 @default.
• W3109024654 hasConceptScore W3109024654C207103383 @default.
• W3109024654 hasConceptScore W3109024654C2777714996 @default.
• W3109024654 hasConceptScore W3109024654C2778341716 @default.
• W3109024654 hasConceptScore W3109024654C2778715236 @default.
• W3109024654 hasConceptScore W3109024654C2779457091 @default.
• W3109024654 hasConceptScore W3109024654C2779832356 @default.
• W3109024654 hasConceptScore W3109024654C38180746 @default.
• W3109024654 hasConceptScore W3109024654C44249647 @default.

• next